What Challenges Exist in Nanotechnology-Driven Gene Therapy?
Despite its potential, nanotechnology-driven gene therapy faces several challenges: 1. Immune Response: The body's immune system may recognize and attack nanoparticles, reducing their efficacy. 2. Toxicity: Some nanoparticles may exhibit toxicity, necessitating careful design and thorough testing to ensure safety. 3. Efficient Targeting: Achieving precise targeting and efficient delivery to specific cells remains a complex task. 4. Scalability: Manufacturing nanoparticles on a large scale while maintaining quality and consistency is challenging.
